Recommendations for genetic testing to reduce the incidence of anthracycline‐induced cardiotoxicity

AIMS: Anthracycline‐induced cardiotoxicity (ACT) occurs in 57% of treated patients and remains an important limitation of anthracycline‐based chemotherapy. In various genetic association studies, potential genetic risk markers for ACT have been identified. Therefore, we developed evidence‐based clin...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Br J Clin Pharmacol
Main Authors: Aminkeng, Folefac, Ross, Colin J. D., Rassekh, Shahrad R., Hwang, Soomi, Rieder, Michael J., Bhavsar, Amit P., Smith, Anne, Sanatani, Shubhayan, Gelmon, Karen A., Bernstein, Daniel, Hayden, Michael R., Amstutz, Ursula, Carleton, Bruce C.
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2016
Fag:
Reviews
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5338111/
https://ncbi.nlm.nih.gov/pubmed/27197003
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13008
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker